Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NM › Santa Fe › NPI 1730684853
Hospital

Presbyterian Healthcare Services

Presbyterian Healthcare Services was paid $21.55M by Medicaid between Oct 2018 and Dec 2024, across 229 billing codes. Its largest line is 99284, emergency room visit (serious) — 18% of everything it billed.

33Billing provider infoPRESBYTERIAN HEALTHCARE SERVICES
SANTA FE, NM 87507
33aNPI1730684853assigned 03/29/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$21.55M
24GClaims395,912
24DCodes billed229
24AFirst – last monthOct 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Mexico

Rank by total paid#12 of 24
Median peer was paid$20.13M
This provider vs. median1.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201813,228$569K
201950,155$2.59M
202035,863$2.16M
202143,132$2.27M
202280,468$4.58M
202397,472$5.10M
2024incomplete75,594$4.28M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 20,445 19,372 $3.86M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 16% 13,173 12,434 $3.52M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 18,273 17,260 $2.55M
74177 Computed tomography, abdomen and pelvis; with contrast material 5.2% 3,232 3,108 $1.12M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 4.7% 7,460 7,295 $1.02M
D2930 Prefabricated stainless steel crown - primary tooth 3.2% 4,548 775 $697K
70450 Computed tomography, head or brain; without contrast material 2.0% 2,451 2,365 $439K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.0% 7,712 6,645 $432K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.5% 2,233 2,192 $329K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.4% 7,427 6,674 $295K
D2934 1.3% 1,808 413 $286K
87631 1.2% 1,968 1,937 $268K
217 more codes
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.2% 6,069 $249K
96375 Therapeutic injection; each additional sequential IV push 1.1% 4,897 $245K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.0% 4,595 $216K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,118 $213K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 5,387 $205K
71046 Radiologic examination, chest; 2 views <1% 3,538 $204K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 24,994 $201K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,930 $199K
80053 Comprehensive metabolic panel <1% 14,737 $194K
71045 Radiologic examination, chest; single view <1% 3,208 $172K
96361 Intravenous infusion, hydration; each additional hour <1% 4,174 $154K
D7140 Extraction, erupted tooth or exposed root <1% 958 $150K
G0378 Hospital observation service, per hour <1% 289 $147K
93976 <1% 932 $138K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,237 $137K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,268 $127K
80048 Basic metabolic panel (calcium, ionized) <1% 10,539 $117K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,319 $115K
0225U <1% 265 $112K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,322 $112K
73562 <1% 1,037 $95K
71275 Computed tomographic angiography, chest, with contrast material <1% 264 $90K
81513 <1% 772 $88K
72125 Computed tomography, cervical spine; without contrast material <1% 376 $80K
84484 <1% 4,778 $77K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,904 $76K
84443 Thyroid stimulating hormone (TSH) <1% 4,699 $75K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 772 $74K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 329 $70K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 646 $68K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 609 $68K
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 419 $67K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 941 $64K
76830 Ultrasound, transvaginal <1% 559 $63K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 437 $62K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,222 $60K
73610 <1% 587 $60K
80076 <1% 5,500 $58K
83690 <1% 7,067 $55K
D0210 Intraoral - complete series of radiographic images <1% 237 $55K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,827 $52K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,301 $50K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,153 $49K
D1206 Topical application of fluoride varnish <1% 292 $48K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,342 $48K
73030 <1% 519 $47K
36415 Collection of venous blood by venipuncture <1% 9,032 $42K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,329 $40K
81025 <1% 3,764 $38K
96376 <1% 1,272 $36K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,470 $34K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,081 $33K
73110 <1% 445 $33K
81001 <1% 7,025 $33K
84702 <1% 1,830 $32K
59025 Fetal non-stress test <1% 257 $31K
83036 Hemoglobin; glycosylated (A1C) <1% 3,648 $31K
85027 <1% 4,827 $31K
83735 <1% 4,330 $31K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 816 $30K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 763 $29K
73130 <1% 371 $28K
87481 <1% 826 $28K
86780 <1% 2,160 $28K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 435 $28K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 830 $28K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,017 $27K
83605 <1% 3,040 $27K
J3490 Unclassified drugs <1% 15,850 $26K
83880 <1% 1,175 $26K
86803 <1% 1,850 $25K
73630 <1% 351 $24K
99204 Doctor's office visit, new patient (more involved) <1% 196 $22K
87650 <1% 985 $21K
84439 <1% 2,342 $21K
82077 <1% 1,803 $20K
84703 <1% 1,820 $20K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 749 $19K
97162 <1% 372 $19K
99214 Doctor's office visit, returning patient (more involved) <1% 246 $19K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 556 $18K
80061 Lipid panel <1% 1,402 $18K
81514 <1% 95 $18K
87077 <1% 2,128 $18K
86850 <1% 1,811 $18K
81003 <1% 4,819 $17K
85379 <1% 1,085 $17K
99213 Doctor's office visit, returning patient (routine) <1% 283 $16K
99203 Doctor's office visit, new patient (routine) <1% 200 $16K
73502 <1% 319 $16K
87653 <1% 433 $15K
D1120 Dental cleaning, child <1% 90 $15K
87634 <1% 224 $15K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 27 $15K
82075 <1% 589 $14K
87186 <1% 1,392 $14K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 50 $14K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 427 $13K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 81 $13K
87081 <1% 1,790 $13K
87040 <1% 808 $12K
76801 <1% 97 $12K
J7120 Ringers lactate infusion, up to 1000 cc <1% 6,101 $11K
85610 <1% 2,420 $11K
86900 <1% 2,170 $11K
94010 <1% 82 $11K
82962 <1% 2,033 $11K
J2704 Injection, propofol, 10 mg <1% 3,063 $10K
72100 <1% 105 $9K
86901 <1% 2,167 $9K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 363 $9K
86762 <1% 608 $9K
87340 <1% 852 $9K
86787 <1% 631 $8K
82805 <1% 147 $8K
82728 <1% 593 $8K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 140 $8K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 15 $8K
D3221 <1% 357 $7K
99201 <1% 190 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,068 $7K
86140 <1% 1,647 $7K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,171 $6K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 252 $6K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 146 $6K
87660 <1% 281 $6K
87510 <1% 281 $6K
87480 <1% 282 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,163 $5K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 14 $5K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 4,525 $5K
85652 <1% 1,021 $5K
D3330 Endodontic therapy, molar tooth (excluding final restoration) <1% 35 $5K
70486 <1% 29 $5K
36000 <1% 639 $4K
93971 <1% 52 $4K
74018 <1% 60 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 53 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 902 $4K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 26 $4K
73080 <1% 56 $4K
94729 <1% 66 $4K
94726 <1% 27 $4K
82570 <1% 729 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,927 $3K
97161 <1% 119 $3K
94760 <1% 661 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,263 $3K
99232 Hospital visit by a doctor, follow-up day <1% 47 $3K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 129 $3K
83655 <1% 202 $3K
82550 <1% 314 $2K
90715 <1% 251 $2K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 31 $2K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 202 $2K
88304 <1% 59 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 16 $2K
82950 <1% 266 $2K
80074 <1% 24 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 866 $1K
82043 <1% 224 $1K
83550 <1% 103 $1K
82607 <1% 65 $1K
80179 <1% 57 $923.44
94762 <1% 19 $901.25
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 619 $892.59
83540 <1% 116 $885.99
J2060 Injection, lorazepam, 2 mg <1% 606 $820.90
80143 <1% 46 $756.37
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 892 $698.97
94375 <1% 13 $634.20
J1170 Injection, hydromorphone, up to 4 mg <1% 551 $605.30
82140 <1% 42 $597.69
J1650 Injection, enoxaparin sodium, 10 mg <1% 66 $562.58
87210 <1% 97 $541.92
84145 <1% 18 $495.43
81002 <1% 172 $479.16
82565 <1% 78 $385.12
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 86 $314.32
83615 <1% 41 $291.99
84156 <1% 76 $289.29
97016 <1% 26 $284.90
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 497 $266.78
85730 <1% 53 $261.66
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 14 $260.57
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 26 $249.89
84550 <1% 44 $212.28
S0028 Injection, famotidine, 20 mg <1% 100 $201.64
J3370 Injection, vancomycin hcl, 500 mg <1% 34 $193.21
82248 <1% 31 $173.45
85018 <1% 61 $160.51
85014 <1% 54 $160.35
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 31 $139.22
J0780 Injection, prochlorperazine, up to 10 mg <1% 73 $131.75
J1815 Injection, insulin, per 5 units <1% 67 $122.86
J3475 Injection, magnesium sulfate, per 500 mg <1% 33 $104.08
J1010 Injection, methylprednisolone acetate, 1 mg <1% 41 $102.06
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 18 $90.69
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 63 $85.85
82247 <1% 15 $84.39
J2550 Injection, promethazine hcl, up to 50 mg <1% 125 $68.41
82040 <1% 12 $65.32
84460 <1% 12 $62.71
84450 <1% 12 $61.35
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 129 $58.32
G0008 Administration of influenza virus vaccine <1% 25 $53.80
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 14 $50.71
88738 <1% 12 $49.95
J1790 Injection, droperidol, up to 5 mg <1% 31 $49.46
84520 <1% 12 $43.23
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 67 $31.86
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 13 $21.96
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 29 $15.06
J1630 Injection, haloperidol, up to 5 mg <1% 15 $14.49
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 60 $12.58
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 15 $11.15
J1171 Injection, hydromorphone, 0.1 mg <1% 14 $4.97

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPOLAND, KIMBERLY (MANAGER)
Same official

Other billing entities under POLAND, KIMBERLY

Full network →
ProviderLocationPaid
Presbyterian Healthcare ServicesAlbuquerque, NM$345.54M
Presbyterian Healthcare ServicesSanta Fe, NM$292K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.